Evidence map›Paper›PMID 35416834›Full record

ArticleEinstein (Sao Paulo, Brazil)2022

Neurovascular manifestations in patients with COVID-19: a case series.

Juliana Cavalcanti de Freitas Reinaux, Karenn Barros Bezerra, Alexandre Sérgio de Araujo Bezerra, Vanessa Garcia Santana, Daniel Lima Souza, Sarah Alcântara Cardoso, Bruna Arrais Dias

Open access · diamondAbstract read
In one paragraph

Article in Einstein (Sao Paulo, Brazil), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Juliana Cavalcanti de Freitas ReinauxHospital Santa Marta, Taguatinga, DF, Brazil.ORCID http://orcid.org/0000-0003-0290-8963
Karenn Barros BezerraHospital Santa Marta, Taguatinga, DF, Brazil.ORCID http://orcid.org/0000-0002-3046-8494
Alexandre Sérgio de Araujo BezerraHospital Santa Marta, Taguatinga, DF, Brazil.ORCID http://orcid.org/0000-0001-6385-2954
Vanessa Garcia SantanaHospital Santa Marta, Taguatinga, DF, Brazil.ORCID http://orcid.org/0000-0003-4539-283X
Daniel Lima SouzaHospital Santa Marta, Taguatinga, DF, Brazil.ORCID http://orcid.org/0000-0002-6783-4523
Sarah Alcântara CardosoHospital Santa Marta, Taguatinga, DF, Brazil.ORCID http://orcid.org/0000-0002-3850-8008
Bruna Arrais DiasHospital Santa Marta, Taguatinga, DF, Brazil.ORCID http://orcid.org/0000-0002-7737-8031
Hospital de Santa Marta · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo describe cerebrovascular manifestations in patients hospitalized for treatment of severe COVID-19, highlighting the comorbidities observed, and those that may play a relevant role as risk factors for severe outcomes.

methodsThis case series retrospective analyzed, from June to November, 2020, ten patients admitted to the emergency department, with positive nasopharyngeal swab polymerase chain reaction assay for SARS-CoV-2, presenting with neurological symptoms and positive findings at brain imaging studies.

resultsIn this sample, the clinical severity of the symptoms varied from mild to critical. Ischemic stroke was observed in four patients, hemorrhagic events occurred in five cases. Three patients evolved with large parenchymal hemorrhage, and one presented petechial bleeding foci. In one case, we observed subarachnoid hemorrhage associated with bilateral hypodensity in both globus pallidus. Typical posterior reversible encephalopathy syndrome findings were observed in one patient on brain computed tomography.

conclusionPatients with neurovascular complications related to COVID-19 had positive findings in brain imaging and neurological symptoms. The pathological entities observed drew attention to the neurological risk of patients with SARS-CoV-2 infection, including worse outcomes in individuals whose medical history includes clinical comorbidities, especially hypertension and obesity.

Indexed as

COVID-19Posterior Leukoencephalopathy SyndromeHumansNeuroimagingRetrospective StudiesSARS-CoV-2

Identifiers

PMID35416834
PMCPMC9648954
OpenAlexW4225665146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.